Real-World Study of Characteristics and Treatment Outcomes Among Patients with KRAS p.G12C-Mutated or Other KRAS Mutated Metastatic Colorectal Cancer

BACKGROUND: The KRAS p.G12C mutation has recently become an actionable drug target. To further understand KRAS p.G12C disease, we describe clinicopathologic characteristics, treatment patterns, overall survival (OS), and real-world progression-free survival (rwPFS) in patients with metastatic colore...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakih, Marwan, Tu, Huakang, Hsu, Hil, Aggarwal, Shivani, Chan, Emily, Rehn, Marko, Chia, Victoria, Kopetz, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Gastrointestinal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355827/
https://www.ncbi.nlm.nih.gov/pubmed/35472176
http://dx.doi.org/10.1093/oncolo/oyac077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355827/
https://www.ncbi.nlm.nih.gov/pubmed/35472176
http://dx.doi.org/10.1093/oncolo/oyac077

Ejemplares similares